| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ddd4d1d0ebc8a7d2c8e7d214d08cf3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2000-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44cdb85f8a3483e31819fba7d3008c76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25968f558600dc16db1c1b69aa6103d6 |
| publicationDate |
2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1142586-A1 |
| titleOfInvention |
Inhibitors against vascular lipid deposition containing chymase-inhibiting substances |
| abstract |
There is provided a preventive or therapeutic agentnfor diseases accompanied by abnormal vascular function innwhich lipid deposition in the blood vessel is involved,nsaid agent comprising a chymase inhibitor as an activeningredient. n As the chymase inhibitor, a quinazoline derivativenrepresented by the following formula is used.n n In the above formula, the ring A represents annaromatic ring. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004071531-A1 |
| priorityDate |
1999-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |